Skip to main content
. 2015 Aug 18;14:90. doi: 10.1186/s12944-015-0088-0

Fig. 4.

Fig. 4

MTT assay cell viability, the cardiomyocytes were pretreated with the indicated concentrations of AAV9-eGFP and AAV9-FrzA for 5 d then further treated with H2O2 (100 μM), and cell viability measured by the MTT test. (* Compared with the control group P <0.05; ** compared with other groups all P <0.05)